The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

May 22 (Reuters) - Lantheus Holdings is weighing a potential sale after getting ‌a takeover offer from private-equity ‌backed Curium Pharma that values it at about $7 ​billion, Bloomberg News reported on Friday, citing people familiar with the matter.

The two companies have been in discussions about ‌a potential ⁠deal that could be weeks away, the report said, adding ⁠that no final decision has been made and there is no guarantee the ​talks will ​result in ​a transaction.

Curium was ‌valued at about $7 billion last year when its owner, CapVest Partners, raised funds for a continuation vehicle for the nuclear medicine company, the report said.

Lantheus and ‌Curium did not ​immediately respond to Reuters' ​request for ​comment.

Shares of the radiopharmaceutical-focused company ‌were trading down nearly ​2% in ​extended trading. They have gained 54.8% so far this year, giving the ​company ‌a market capitalization of about $6.15 billion.

(Reporting ​by Siddhi Mahatole in Bengaluru; Editing ​by Shilpi Majumdar)